Cargando…
Effects of vildagliptin on wound healing and markers of inflammation in patients with type 2 diabetic foot ulcer: a prospective, randomized, double-blind, placebo-controlled, single-center study
INTRODUCTION: Diabetic foot ulcers (DFU) are one of the leading long-term complications experienced by patients with diabetes. Dipeptidyl Peptidase 4 inhibitors (DPP4is) are a class of antihyperglycemic medications prescribed to patients with diabetes to manage glycaemic control. DPP4is may also hav...
Autores principales: | Vangaveti, Venkat N., Jhamb, Shaurya, Hayes, Oliver, Goodall, Julie, Bulbrook, Jacqueline, Robertson, Kelvin, Biros, Erik, Sangla, Kunwarjit S., Malabu, Usman H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716851/ https://www.ncbi.nlm.nih.gov/pubmed/36456992 http://dx.doi.org/10.1186/s13098-022-00938-2 |
Ejemplares similares
-
Influence of Ethnicity on Outcomes of Diabetes Inpatient Hypoglycemia: an Australian Perspective
por: Malabu, Usman H, et al.
Publicado: (2020) -
Electromechanical therapy in diabetic foot ulcers patients: A systematic review and meta-analysis
por: Rathnayake, Ayeshmanthe, et al.
Publicado: (2023) -
Serum procollagen type 1 N propeptide: A novel diagnostic test for diabetic foot osteomyelitis – A case–control study
por: Hayes, Oliver G, et al.
Publicado: (2018) -
The efficacy of inflammatory markers in diagnosing infected diabetic foot ulcers and diabetic foot osteomyelitis: Systematic review and meta-analysis
por: Sharma, Harman, et al.
Publicado: (2022) -
Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma
por: Malabu, Usman Hammawa, et al.
Publicado: (2011)